Controversies in CTO PCI

A consultant cardiologist at University of Catania, Catania, Italy. Features in 1 video on Wondr Medical. Alfredo Galassi generally speaks on Coronary Interventions, Chronic Total Occlusion (CTO), and Stable Coronary Artery Disease (CAD).

Dimitrios Karmpaliotis, MD, PhD is a member of the Center for Interventional Vascular Therapy at Columbia University Medical Center since 2014. He has served as the director of Chronic Total Occlusions, Complex and High Risk Angioplasty Program at NYPH/CUMC and is an Associate Professor of Medicine at Columbia University Medical School. Dr. Karmpaliotis graduated from the University of Athens School of Health Sciences in Greece (1996). He trained in Internal Medicine at Brown University School of Medicine, Critical Care Medicine at Massachusetts General Hospital and Brigham and Women's Hospital (Harvard Medical School). He then trained in Cardiology at Beth Israel Deaconess Medical Center (Harvard Medical School) and Interventional Cardiology at Emory University. Before coming to Columbia University, Dr. Karmpaliotis was instrumental in building a world-class interventional cardiology program at Piedmont Heart Center in Atlanta, Georgia. Dr. Karmpaliotis has served as principal investigator on more than 50 clinical trials, and has more than 200 publications in peer-reviewed journals, with special interest in the development of techniques for treating chronic total occlusions in coronary arteries, Left Main Interventions and Advanced Hemodynamic Support. As part of the CIVT faculty, Dr. Karmpaliotis developed master-technician training programs, co-directed the complex coronary fellowship program at NYPH/CUMC, and has been an associate director of Transcatheter Cardiovascular Therapeutic Conference, as well as a co-director of the CTO Summit.

After training in Scotland, Interventional Cardiology Fellowship at CUMC, and Clinical Research Fellowship at Harvard University, she was a Consultant Interventional Cardiologist at the Golden Jubilee National Hospital and Associate Professor of Cardiology at the University of Glasgow, prior to moving back to New York in 2022.

Works at Showa University, Northern Yokohama Hospital, Kanagawa, Japan. Features in 2 videos on Wondr Medical. Masahiko Ochiai generally speaks on Chronic Total Occlusion (CTO), Live Cases, Bifurcation, Total Occlusion and Bifurcation Interventions, and Coronary Interventions.

An interventional cardiologist at National Taiwan University Hospital, Taipei, Taiwan. Features in 4 videos on Wondr Medical. Paul Hsien-Li Kao generally speaks on Chronic Total Occlusion (CTO), Cardiac Valves, Cardiovascular Surgery – Valves, Coronary Interventions, and Stable Coronary Artery Disease (CAD).

A consultant cardiologist at VU University Medical Centre, Amsterdam, The Netherlands. Features in 4 videos on Wondr Medical. Paul Knaapen generally speaks on Chronic Total Occlusion (CTO), Stable Coronary Artery Disease (CAD), CT Coronary Angiography, and Coronary Interventions.

A pediatric cardiologist at Wellington Hospital, Wellington, New Zealand. Features in 4 videos on Wondr Medical. Scott Harding generally speaks on Chronic Total Occlusion (CTO), Cardiac Valves, Cardiovascular Surgery – Valves, Coronary Interventions, and Stable Coronary Artery Disease (CAD).

A chief director of cardiovascular intervention at Tokyo General Hospital, Tokyo, Japan. Features in 4 videos on Wondr Medical. Toshiya Muramatsu generally speaks on Chronic Total Occlusion (CTO), Cardiac Valves, Cardiovascular Surgery – Valves, Coronary Interventions, and Stable Coronary Artery Disease (CAD).

After completing his M.D. at Tulane Medical School, Bill Lombardi went on to the University of Utah, Salt Lake City for his internal medicine residency and fellowships in cardiology, heart failure/cardiac transplant, and interventional cardiology. Dr. Lombardi then returned home to Washington State and joined St. Joseph’s Hospital in Bellingham. During the 13 years that he was at St. Joseph’s, Dr. Lombardi helped to develop novel CTO techniques and technologies and was fundamental to the inception of the “hybrid algorithm” to facilitate reproducibly successful outcomes in chronic total occlusion and complex lesion PCI. During this time he was also active in physician training, CME courses and proctoring. Dr. Lombardi joined the University of Washington Medical Center in 2014 as associate clinical professor and director of the Complex Coronary Disease Therapies Program. He is certified in interventional cardiology and cardiovascular disease by the American Board of Internal Medicine. Dr. Lombardi's interests include sailing, fishing, and spending time with family.

Dr. William Nicholson is acting Associate Professor of Medicine at Emory University School of Medicine and Director of Complex Coronary and Cardiac Intervention at Emory Healthcare. Dr. Nicholson also serves as the program director for the Advanced Complex High-Risk Interventional Procedures (CHIP) fellowship at Emory University Hospital. Dr. Nicholson came to Emory in 2020 after fourteen years in private interventional cardiology practice in York, Pennsylvania. While in private practice, Dr. Nicholson founded and developed that institution’s carotid stenting program, structural heart program, transcatheter aortic valve replacement program, and the complex coronary intervention program. He also has become nationally and internationally recognized for his expertise in treatment of Chronic Total Occlusions (CTO’s). He is a perennial live case operator for nationally televised conferences. Dr. Nicholson formerly trained at Emory University Hospital having completed his general cardiology and interventional fellowship in 2006. He completed his medical residency at Brown University Hospitals where he also served as Chief Medical Resident. He is a graduate of Pennsylvania State College of Medicine.